Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, dyslipidemia, obstructive sleep apnea or cardiovascular disease)
About 59.8% of the study sample had overweight/obesity and 41.9% had T2D
Related: Affordable Skin Whitening Treatment in Bangladesh
It targets the same two receptors as Mounjaro, GLP-1 and GIP, but adds a third: the glucagon receptor
The increased blood flow will enhance your pumps, strength, and endurance in the gym
Inte oroliga Jag skulle definitivt avrda frn att anvnda det